Literature DB >> 31024199

Clinical, anthropometric, biochemical and histological character of nonalcoholic fatty liver disease without Insulin Resistance.

Shahinul Alam1, Kamrul Anam1, Saiful Islam1, Golam Mustafa1, Ayub Al Mamun1, Nooruddin Ahmad1.   

Abstract

OBJECTIVES: Nonalcoholic Fatty Liver Disease (NAFLD) is thought to be a hepatic manifestation of Metabolic Syndrome (MS) or Insulin Resistance (IR). The aim of the study was to explore the clinical, anthropometric, metabolic, biochemical and histological profile of NAFLD patients without IR by comparing it with NAFLD with IR.
METHODS: Total 851 patients with sonographic evidence of fatty liver were included. These patients underwent clinical, anthropometric, biochemical and histological evaluation. IR was calculated using the homeostatic model assessment. Liver biopsy done in 285 patients who consented for the procedure and who had MS or raised ALT.
RESULTS: Among 851 NAFLD patients, 561(65.9%) patients were without IR and 290 (34.1%) patients were with IR. The proportion of male sex [230 (41.0%) vs. 89 (30.7%); P = 0.046] were higher but diabetes [19.10% vs. 39.0%; P = 0.000] and MS were [58.80%vs. 78.10%; P = 0.014] significantly lower in non IR group. Body Mass Index (BMI) kg/m2 and Waist Circumference (WC) in cm were also lower in non IR group: [26.6 ± 3.5 vs. 27.9 ± 4.3; P = 0.002] and [93.3 ± 8.4 vs. 95.9 ± 8.4; P = .003]. Lipid profile, ALT, AST and ALP were not differed between the groups. Histopathology reports revealed that lobular inflammation, ballooning and fibrosis were similar in two groups, only steatosis score was higher in IR group [2.0 ± 0.7 vs. 1.8 ± 0.8; P = 0.007].
CONCLUSION: There are significant proportion of NAFLD patients without IR in Bangladesh. NAFLD patients without IR predominantly male, had lower BMI, WC, MS and diabetes. Histologically NAFLD without IR equally severe with ballooning, lobular inflammation and fibrosis except steatosis. Insulin resistance is the principal but not the sole factor for NAFLD in our population.

Entities:  

Keywords:  BMI, Body Mass Index; Bangladesh; IR, Insulin Resistance; MS, Metabolic Syndrome; NAFLD, Nonalcoholic Fatty Liver Disease; WC, Waist Circumference; fatty liver; homeostatic model assessment (HOMA); insulin resistance; nonalcoholic fatty liver disease

Year:  2018        PMID: 31024199      PMCID: PMC6477145          DOI: 10.1016/j.jceh.2018.06.011

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  41 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

Review 2.  Non-alcoholic steatohepatitis in the Asia-Pacific region: future shock?

Authors:  Shivakumar Chitturi; Geoffrey C Farrell; Jacob George
Journal:  J Gastroenterol Hepatol       Date:  2004-04       Impact factor: 4.029

3.  Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.

Authors:  E Bonora; G Targher; M Alberiche; R C Bonadonna; F Saggiani; M B Zenere; T Monauni; M Muggeo
Journal:  Diabetes Care       Date:  2000-01       Impact factor: 19.112

4.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Authors:  Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

5.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

6.  The new BMI criteria for asians by the regional office for the western pacific region of WHO are suitable for screening of overweight to prevent metabolic syndrome in elder Japanese workers.

Authors:  Erdembileg Anuurad; Kuninori Shiwaku; Akiko Nogi; Keiko Kitajima; Byambaa Enkhmaa; Kumiko Shimono; Yosuke Yamane
Journal:  J Occup Health       Date:  2003-11       Impact factor: 2.708

7.  Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets.

Authors:  Jean-Marc Schwarz; Peter Linfoot; Doris Dare; Karmen Aghajanian
Journal:  Am J Clin Nutr       Date:  2003-01       Impact factor: 7.045

8.  Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.

Authors:  Elisabetta Bugianesi; Paola Manzini; Sergio D'Antico; Ester Vanni; Filomena Longo; Nicola Leone; Paola Massarenti; Antonio Piga; Giulio Marchesini; Mario Rizzetto
Journal:  Hepatology       Date:  2004-01       Impact factor: 17.425

9.  Nonalcoholic fatty liver disease in patients with type 2 diabetes.

Authors:  Zobair M Younossi; Terry Gramlich; Christi A Matteoni; Navdeep Boparai; Arthur J McCullough
Journal:  Clin Gastroenterol Hepatol       Date:  2004-03       Impact factor: 11.382

10.  Correlations of C-reactive protein levels with anthropometric profile, percentage of body fat and lipids in healthy adolescents and young adults in urban North India.

Authors:  Naval K Vikram; Anoop Misra; Manjari Dwivedi; Rekha Sharma; R M Pandey; Kalpana Luthra; Ananya Chatterjee; Vibha Dhingra; B L Jailkhani; K K Talwar; Randeep Guleria
Journal:  Atherosclerosis       Date:  2003-06       Impact factor: 5.162

View more
  3 in total

1.  Fetuin-A and Fetuin-B in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis and Meta-Regression.

Authors:  Xiongfeng Pan; Atipatsa C Kaminga; Jihua Chen; Miyang Luo; Jiayou Luo
Journal:  Int J Environ Res Public Health       Date:  2020-04-15       Impact factor: 3.390

2.  Association of non-alcoholic fatty liver disease with coronary artery calcification progression: a systematic review and meta-analysis.

Authors:  George Koulaouzidis; Dafni Charisopoulou; Michał Kukla; Wojciech Marlicz; Grażyna Rydzewska; Anastasios Koulaouzidis; Karolina Skonieczna-Żydecka
Journal:  Prz Gastroenterol       Date:  2021-09-17

3.  The clinical and histological characteristics of patients with biopsy-proven non-alcoholic fatty liver disease in the absence of insulin resistance.

Authors:  Coskun Ozer Demirtas; Aybuke Sapmaz; Burak Ahmet Gurel; Hasan Kizmaz; Tuncay Ulu; Seyma Gorcin Karaketir; Seyhan Hidiroglu; Yusuf Yilmaz
Journal:  Hepatol Forum       Date:  2020-09-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.